Zhu Jianguo, Song Jukun, Liu Zezhen, Han Jin, Luo Heng, Liu Yunlin, Jia Zhenyu, Dong Yuanbo, Zhang Wei, Jiang Funeng, Wu Chinlee, Sun Zaolin, Zhong Weide
Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou 510180, China.
Urology Key Laboratory of Guangdong Province, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, 510230, China.
Sci Rep. 2016 Oct 21;6:35682. doi: 10.1038/srep35682.
Association between allergic conditions and prostate cancer risk has been investigated for many years. However, the results from available evidence for the association are inconsistent. We conducted a meta-analysis to evaluate the relationship between allergic conditions (asthma, atopy, hay fever and "any allergy") and risk of prostate cancer. The PubMed and Embase databases were searched to screen observational studies meeting our meta-analysis criteria. Study selection and data extraction from included studies were independently performed by two authors. Twenty studies were considered eligible involving 5 case-control studies and 15 cohort studies. The summary relative risk (RR) for developing prostate cancer risk was 1.04 (95%CI: 0.92-1.17) for asthma, and 1.25 (95%CI: 0.74-2.10) for atopy, 1.04 (95%CI: 0.99-1.09) for hay fever, 0.96 (95%CI: 0.86-1.06) for any allergy. In the Subgroup and sensitivity analysis, similar results were produced. Little evidence of publication bias was observed. The present meta-analysis of observational studies indicates that no indication of an association between allergic conditions and risk of prostate cancer was found, and the meta-analysis does not support neither the original hypothesis of an overall cancer protective effect of allergic conditions, nor that of an opposite effect in the development of prostate cancer.
过敏状况与前列腺癌风险之间的关联已被研究多年。然而,现有证据对于该关联的结果并不一致。我们进行了一项荟萃分析,以评估过敏状况(哮喘、特应性、花粉症和“任何过敏”)与前列腺癌风险之间的关系。检索了PubMed和Embase数据库,以筛选符合我们荟萃分析标准的观察性研究。两名作者独立进行纳入研究的选择和数据提取。共纳入20项研究,其中包括5项病例对照研究和15项队列研究。哮喘患者患前列腺癌风险的汇总相对风险(RR)为1.04(95%CI:0.92 - 1.17),特应性为1.25(95%CI:0.74 - 2.10),花粉症为1.04(95%CI:0.99 - 1.09),任何过敏为0.96(95%CI:0.86 - 1.06)。在亚组和敏感性分析中,得出了类似的结果。未观察到明显的发表偏倚证据。目前对观察性研究的荟萃分析表明,未发现过敏状况与前列腺癌风险之间存在关联的迹象,该荟萃分析既不支持过敏状况对癌症具有总体保护作用的原假设,也不支持其在前列腺癌发生中具有相反作用的假设。